drugset / Trial / NCT00136617

Outpatient Treatment of Alcohol Withdrawal Syndrome

NCT00136617

Phase 3 Completed 165 enrolled Hvidovre University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare a fixed-schedule therapy versus a symptom-triggered therapy for alcohol withdrawal syndrome in medical outpatients. Objectives: * Self-governance in monitoring AWS (alcohol withdrawal syndrome) symptoms and medication * Clinically controlled trial of two regimens for medical treatment of alcohol withdrawal syndrome * Outpatient treatment of alcohol withdrawal syndrome

Timeline

Start
2003-08
Primary completion
2006-07
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject chlordiazepoxide Small molecule 200 mg
Subject chlordiazepoxide Small molecule 300 mg